These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37494846)

  • 1. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
    Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
    Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer.
    Sharma A; Weitz P; Wang Y; Liu B; Vallon-Christersson J; Hartman J; Rantalainen M
    Breast Cancer Res; 2024 Jan; 26(1):17. PubMed ID: 38287342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved breast cancer histological grading using deep learning.
    Wang Y; Acs B; Robertson S; Liu B; Solorzano L; Wählby C; Hartman J; Rantalainen M
    Ann Oncol; 2022 Jan; 33(1):89-98. PubMed ID: 34756513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images.
    Sharma A; Lövgren SK; Eriksson KL; Wang Y; Robertson S; Hartman J; Rantalainen M
    Breast Cancer Res; 2024 Aug; 26(1):123. PubMed ID: 39143539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
    Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
    Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
    Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
    EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer.
    Zilenaite-Petrulaitiene D; Rasmusson A; Besusparis J; Valkiuniene RB; Augulis R; Laurinaviciene A; Plancoulaine B; Petkevicius L; Laurinavicius A
    Virchows Arch; 2024 Jan; ():. PubMed ID: 38217716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep learning-based risk stratification of preoperative breast biopsies using digital whole slide images.
    Boissin C; Wang Y; Sharma A; Weitz P; Karlsson E; Robertson S; Hartman J; Rantalainen M
    Breast Cancer Res; 2024 Jun; 26(1):90. PubMed ID: 38831336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR
    Hu J; Lv H; Zhao S; Lin CJ; Su GH; Shao ZM
    J Thorac Dis; 2023 May; 15(5):2528-2543. PubMed ID: 37324098
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mondol RK; Millar EKA; Graham PH; Browne L; Sowmya A; Meijering E
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer.
    Lubbock ALR; Stewart GD; O'Mahony FC; Laird A; Mullen P; O'Donnell M; Powles T; Harrison DJ; Overton IM
    BMC Med; 2017 Jun; 15(1):118. PubMed ID: 28648142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
    Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
    Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer.
    Ren X; Song Y; Zhang Y; Wu H; Chen L; Pang J; Zhou L; Shen S; Liang Z
    BMC Cancer; 2022 May; 22(1):548. PubMed ID: 35568835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of a deep learning prognostic model based on digital pathology images of stage III colorectal cancer.
    Zhou X; Lu Y; Wu Y; Yu Y; Liu Y; Wang C; Zhao Z; Wang C; Gao Z; Li Z; Zhao Y; Cao W
    Eur J Surg Oncol; 2024 Jul; 50(7):108369. PubMed ID: 38703632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
    Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
    Su Z; Niazi MKK; Tavolara TE; Niu S; Tozbikian GH; Wesolowski R; Gurcan MN
    PLoS One; 2023; 18(4):e0283562. PubMed ID: 37014891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.